A next generation PEG-free LNP technology that actively targets myeloid cells through selective binding to the myeloid lectin DC-SIGN receptor
Time: 11:45 am
day: Conference Day Two
Details:
- Pullulan LNPs are PEG-free and selectively targets macrophages and dendritic cells through specific binding to the C-type lectin receptor DC-SIGN.
- PEG-free Pullulan LNP could avoid PEG-dependent undesirable reactions such as allergy, anaphylaxis, and accelerated blood clearance
- Pullulan LNPs are ideal for tumor environment modulation, cancer vaccines, and infectious disease vaccines
